Federico Rafael Galluccio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Federico Rafael Galluccio has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- María José Sadonio
Servicio de Clínica Médica, Hospital J. B. Iturraspe, Santa Fe, Argentina
3 shared publications - Maximiliano Gabriel Castro
Servicio de Clínica Médica, Hospital J. B. Iturraspe, Santa Fe, Argentina. Facultad de Ciencias Médicas, Universidad Nacional del Litoral, Santa Fe, Argentina
3 shared publications - Ana Paula Amato
Servicio de Clínica Médica, Hospital J.B. Iturraspe, Santa Fe, Argentina
2 shared publications - Ana Verónica Willa
Hospital Regional José Bernardo Iturraspe. Servicio de Clínica Médica
1 shared publication - Erwin Alexander Rottoli
Servicio de Clínica Médica, Hospital J.B. Iturraspe, Santa Fe, Argentina
1 shared publication - Fernanda Argarañá
Sección de Microbiología, Hospital J.B. Iturraspe, Santa Fe, Argentina; Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina
1 shared publication
Latest Publications
- Open Access
- 28 March 2026
- Published by Elsevier in Revista Argentina de Microbiologia
- Vol. 58 (3) , 100717
Predictors of rectal carriage of carbapenemase-producing Gram-negative bacteria in general wards: A case–control study
- 28 March 2026
- Published by Elsevier in Revista Argentina de Microbiologia
- Vol. 58 (3) , 100717
Open AccessPredictors of rectal carriage of carbapenemase-producing Gram-negative bacteria in general wards: A case–control study
- Open Access
- 26 June 2025
- Published by Universidad Nacional de Córdoba in Revista de la Facultad de Ciencias Médicas de Córdoba
- Vol. 82 (2) , 237-252
Variabilidad en el tamizaje de la infección por el Virus de la Inmunodeficiencia Humana
Introduction: Due to potential disruptions in HIV care services caused by COVID-19, this study aimed to evaluate the variability in HIV screening between 2019 and 2022 among adults hospitalized in the general ward of a tertiary care hospital in Santa Fe. Materials and Methods: This ambispective and observational study evaluated the request for HIV serologic screening in patients selected through randomized sampling at a 2:1 ratio from October to December of the years 2019 to 2022. The impact of the COVID-19 pandemic during 2020 was compared to 2019, followed by the impact of an institutional intervention aimed at increasing the rate of HIV screening requests. Results: A total of 995 subjects were included. HIV screening was requested for 47.4% (n=472) of them, with a positivity rate of 1.7% (n=8). In 2020, HIV screening decreased compared to 2019 (34% vs. 43.9%, p<0.001), and increased to 84.2% in 2022 (p<0.001). In the multivariate analysis, the odds of HIV screening decreased with age (OR 0.986), while hospital admission in 2019 and 2022 (OR 1.48 y 9.76, respectively) increased it. Discussion: The COVID-19 pandemic exacerbated the already low rate of HIV screening requests, which was also influenced by the age of the subjects. However, through institutional guidelines, this situation was successfully reversed in 2022.
- 26 June 2025
- Published by Universidad Nacional de Córdoba in Revista de la Facultad de Ciencias Médicas de Córdoba
- Vol. 82 (2) , 237-252
Open AccessVariabilidad en el tamizaje de la infección por el Virus de la Inmunodeficiencia Humana
Introduction: Due to potential disruptions in HIV care services caused by COVID-19, this study aimed to evaluate the variability in HIV screening between 2019 and 2022 among adults hospitalized in the general ward of a tertiary care hospital in Santa Fe. Materials and Methods: This ambispective and observational study evaluated the request for HIV serologic screening in patients selected through randomized sampling at a 2:1 ratio from October to December of the years 2019 to 2022. The impact of the COVID-19 pandemic during 2020 was compared to 2019, followed by the impact of an institutional intervention aimed at increasing the rate of HIV screening requests. Results: A total of 995 subjects were included. HIV screening was requested for 47.4% (n=472) of them, with a positivity rate of 1.7% (n=8). In 2020, HIV screening decreased compared to 2019 (34% vs. 43.9%, p<0.001), and increased to 84.2% in 2022 (p<0.001). In the multivariate analysis, the odds of HIV screening decreased with age (OR 0.986), while hospital admission in 2019 and 2022 (OR 1.48 y 9.76, respectively) increased it. Discussion: The COVID-19 pandemic exacerbated the already low rate of HIV screening requests, which was also influenced by the age of the subjects. However, through institutional guidelines, this situation was successfully reversed in 2022.
- Open Access
- 19 November 2024
- Published by Universidad Nacional del Litoral in SigMe
- No. 2,p. e0016
Angioedema y lupus eritematoso sistémico: ¿Una asociación inusual o poco sospechada?
Según la Organización Mundial de Alergia, el angioedema se caracteriza por una reacción vascular transitoria de los tejidos dérmicos- subcutáneos profundos o de los tejidos mucosos- submucosos, con un aumento localizado de la permeabilidad de los vasos sanguíneos que provoca la inflamación del tejido. Esta patología puede ser hereditaria o adquirida. El angioedema se asocia a lupus eritematoso sistémico (LES) hasta en un 2% de casos. A continuación se presentan una serie de tres casos de pacientes con diagnóstico de angioedema asociado a LES y una revisión de la literatura disponible sobre el tema.
- 19 November 2024
- Published by Universidad Nacional del Litoral in SigMe
- No. 2,p. e0016
Open AccessAngioedema y lupus eritematoso sistémico: ¿Una asociación inusual o poco sospechada?
Según la Organización Mundial de Alergia, el angioedema se caracteriza por una reacción vascular transitoria de los tejidos dérmicos- subcutáneos profundos o de los tejidos mucosos- submucosos, con un aumento localizado de la permeabilidad de los vasos sanguíneos que provoca la inflamación del tejido. Esta patología puede ser hereditaria o adquirida. El angioedema se asocia a lupus eritematoso sistémico (LES) hasta en un 2% de casos. A continuación se presentan una serie de tres casos de pacientes con diagnóstico de angioedema asociado a LES y una revisión de la literatura disponible sobre el tema.